Nabumetone Tablet
Product Images NDC 63629-8509

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 63629-8509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a chart showing the plasma concentrations of Nabumetone's active metabolite (BMNA) at steady state in participants who were given 1000mg or 2000mg of Nabumetone once daily. The chart represents 31 participants who took 1000mg/day and 12 participants who took 2000mg/day. The X-axis represents time in hours and the Y-axis represents BMNA plasma concentrations.*

FDA Label Image

Label (Lbl636298509)

NILD is a pharmaceutical company that produces Nabumetone Tablets USP, 750 mg. The medication should be kept out of reach of children and stored at a temperature of 20° to 25°C. It can be dispensed in a tight, light-resistant container as defined in the USP, with a child-resistant closure. The NDC number for Nabumetone Tablets USP 750 mg is 63629-8509-1.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

6-methoxy-2-naphthylacetic acid (SMNA) is a chemical compound with the molecular formula COOH-CHgO.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.